title: Neuronal nitric oxide synthase inhibition differentially affects oxytocin and vasopressin secretion in salt loaded rats.
abstract: Nitric oxide, an endogenous gas produced by nitric oxide synthase (NOS), has been described as a neuromodulator of hormone secretion, including the neurohypophysial peptides oxytocin (OT) and vasopressin (AVP), hormones involved in the sodium and water homeostasis. The presence of NOS in the hypothalamic nuclei as well as in the circumventricular organs suggests a nitrergic regulation of OT and AVP secretion. Thus, the aim of this study was to evaluate the effect of 7-nitroindazole (7-NI), a selective inhibitor of neuronal NOS, in the plasma OT and AVP levels in rats submitted to a short and long-term salt loading. We also evaluated the NOS activity in the supraoptic (SON) and paraventricular (PVN) hypothalamic nuclei. Our data showed an increase of plasma OT and AVP levels in both short and long-term salt loading. The augment of plasma OT and AVP levels was accompanied by an increase of NOS activity in the SON and PVN. The injection of 7-NI potentiated the increase of plasma OT induced by salt loading, but inhibited the increase of plasma AVP in the same experimental conditions. These results indicate that, under short and prolonged osmotic stimulation, nitric oxide may differentially control the neurohypophysial secretion.
authors.affiliation: Department of Physiology, School of Medicine of Ribeirão Preto, São Paulo, Brazil.
authors.forename: Renato Rizo
authors.initials: RR
authors.lastname: Ventura
authors.forename: Alexandre
authors.initials: A
authors.lastname: Giusti-Paiva
authors.forename: Dayane Aparecida
authors.initials: DA
authors.lastname: Gomes
authors.forename: Lucila L K
authors.initials: LL
authors.lastname: Elias
authors.forename: José
authors.initials: J
authors.lastname: Antunes-Rodrigues
mesh_terms: D000818:Animals; D002956:Citrulline / Q000378:metabolism; D004347:Drug Interactions; D007191:Indazoles / Q000494:pharmacology*; D008297:Male; D009281:Naphthalenes; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009994:Osmolar Concentration; D010082:Oxepins; D010121:Oxytocin / Q000097:blood*; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects* / Q000201:enzymology; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats; D017208:Rats, Wistar; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage* / Q000097:blood; D013495:Supraoptic Nucleus / Q000187:drug effects* / Q000201:enzymology; D013997:Time Factors; D014316:Tritium / Q000378:metabolism; D014667:Vasopressins / Q000097:blood*
chemical_list: C461941:1-phenyl-1,4-epoxy-1H,4H-naphtho(1,8-de)(1,2)dioxepin; D007191:Indazoles; D009281:Naphthalenes; D010082:Oxepins; D017673:Sodium Chloride, Dietary; D014316:Tritium; D014667:Vasopressins; D002956:Citrulline; D010121:Oxytocin; D019001:Nitric Oxide Synthase; C080122:7-nitroindazole